Canada markets closed
  • S&P/TSX

    19,669.17
    +49.07 (+0.25%)
     
  • S&P 500

    4,140.06
    -5.13 (-0.12%)
     
  • DOW

    32,832.54
    +29.04 (+0.09%)
     
  • CAD/USD

    0.7779
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    90.52
    -0.24 (-0.26%)
     
  • BTC-CAD

    30,606.00
    +685.55 (+2.29%)
     
  • CMC Crypto 200

    559.83
    +16.96 (+3.12%)
     
  • GOLD FUTURES

    1,805.90
    +0.70 (+0.04%)
     
  • RUSSELL 2000

    1,941.21
    +19.39 (+1.01%)
     
  • 10-Yr Bond

    2.7650
    -0.0750 (-2.64%)
     
  • NASDAQ futures

    13,226.75
    +43.50 (+0.33%)
     
  • VOLATILITY

    21.29
    +0.14 (+0.66%)
     
  • FTSE

    7,482.37
    +42.63 (+0.57%)
     
  • NIKKEI 225

    28,249.24
    +73.34 (+0.26%)
     
  • CAD/EUR

    0.7625
    -0.0001 (-0.01%)
     

Invacare Corporation to Participate in the 22nd Annual CJS Securities New Ideas Summer Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ELYRIA, Ohio, June 28, 2022--(BUSINESS WIRE)--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022.

The company’s management team will be available for 1x1 meetings with interested investors.

About Invacare Corporation

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220628005834/en/

Contacts

Lois Lee
loislee@invacare.com
440-329-6435

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting